AzTrials
AzTrials

Carious DentinNCT03285022

Postoperative Hypersensitivity and Digital Radiographic Assessment of a Zinc Modified Versus a Conventional Glass Ionomer Cement in Deep Carious Lesion: Randomized Controlled Clinical Trial

A study testing Partial caries removel techniques in people with Carious Dentin, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aim to evaluate the difference between the effect of zinc modified glass ionomer and conventional glass ionomer on the success of partial caries removel technique Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Carious Dentin
What is being tested?
Partial caries removel techniques
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
No sites listed yet
Study dates
20 Oct 2017to 20 Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male or female (>18 y)
  • patient with At least 1 deep carious lesion
  • Clinical symptoms of reversible pulpitis with positive pulp response

Who cannot join

  • 1. Patient suffer from irreversible pulpitis (pain with hot or instant pain lasting for a while, resistant to analgesic) 2. Presence of any sign of periapical lesion (like sinus tract ) 3. Teeth with periodontal problem 4. Anterior teeth (material used for non aesthetic region) 5. Pregnant women, to avoid multiple exposure to x ray 6. Patients unable to give consent(mentally retarted, or refuse to right a consent)

Trial locations and contacts

No sites are listed yet.

Dina Mounir Elkady, Assitant lecturer contact

01004297317

Dina.elkady@dentistry.cu.edu.eg

Mohamed Riad Farid, Professor contact

01223113166

mriad_52@yahoo.com

About this study

The study aim to evaluate the difference between the effect of zinc modified glass ionomer and conventional glass ionomer on the success of partial caries removel technique

Read the detailed description

The zinc ion has an antibacterial effect which could increase the success of partial caries removel technique by decreasing the bactrial population .

Conditions
Carious Dentin
Being tested
Partial caries removel techniques
Keywords
Incomplete caries removel, Partial caries removel
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Partial caries removel techniquesProcedure or surgery

    Also called Partial caries removel

    Removel of all superfacial dentin and leaving the inner affectted dentin

Study groups in NCT03285022
Study groupRoleWhat they receive
Zinc modified glass ionomerExperimentalZinc modified glass ionomer (chemfill rock) galss ionomer used as restoration for posterior teeth in case of partial caries removel
Receives: Procedure: Partial caries removel techniques
Conventionel glass ionomerActive comparatorConventional glass ionomer used as restoration for posterior teeth in case of partial caries removel
Receives: Procedure: Partial caries removel techniques

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Digital radigraphic assessment

    The presence of periapical change or change in lamina dura change after the procedure

    Measured: At baseline ,3months and 6 months

Secondary outcomes (1)
  1. Post opreative hypersenstivity

    The presence or absence of pain with thermal

    Measured: Baseline ,at 3 months and at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2017
  2. Study start20 Oct 2017 (estimated)
  3. Primary completion20 Apr 2018 (estimated)
  4. Study completion20 Apr 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03285022
Sponsor's protocol ID
CEBD-CU-2017-09-17
Status last verified
Sep 2017
First submitted
14 Sep 2017
Last updated
15 Sep 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Partial caries removel techniques in people with Carious Dentin, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dina Mounir Elkady, Assitant lecturer (01004297317, Dina.elkady@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Digital radigraphic assessment (time frame: At baseline ,3months and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in